Questionnaire and Laboratory Data on Vitiligo Vulgaris
Completed
Conditions studied: Vitiligo Vulgaris
In brief
Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.
Key facts
- Study ID
- NCT01206374
- Run by
- St. Luke's-Roosevelt Hospital Center
- People needed
- 57
- Starts
- 2010-08-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2015-05-25
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of Vitiligo Vulgaris
- Ability to sign consent
You may not qualify if…
- Pregnant
- Inability to sign consent
- Inability to complete questionnaire
Where it is running
- Department of Dermatology, Beth Israel Medical Center — New York, New York, United States
- Department of Dermatology, St. Luke's-Roosevelt Hospital Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.